T26 (Carbamazepine extended-release 200 mg)

Pill imprint T26 has been identified as Carbamazepine extended-release 200 mg.

Carbamazepine is used in the treatment of bipolar disorder; trigeminal neuralgia; epilepsy; schizoaffective disorder; diabetic peripheral neuropathy (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for T26

Carbamazepine extended-release 200 mg T26
Carbamazepine extended-release
Imprint:
T26
Strength:
200 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Taro Pharmaceutical Industries Ltd.
National Drug Code (NDC):
51672-4124
Inactive Ingredients:
corn starch
diethyl phthalate
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)